Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal muscle physiology (HP:0011804)help
Parent Node:
expand
Muscle weakness (HP:0001324)help
..Starting node
..expand
Proximal muscle weakness (HP:0003701)help
Term ID: 3701
Name: Proximal muscle weakness
Synonym: Muscle weakness, proximal; Proximal limb muscle weakness; Proximal limb weakness; Proximal neurogenic muscle weakness; Weakness in muscles of upper arms and upper legs
Definition: A lack of strength of the proximal muscles.
Comments:
Reference: HP:0003701
Genes and Diseases:
 
       Child Nodes:
........expandGowers sign (HP:0003391) help
........expandLate-onset proximal muscle weakness (HP:0003694) help
........expandProximal muscle weakness in lower limbs (HP:0008994) help
................... HP:0003731 Quadriceps muscle weakness
........expandProximal muscle weakness in upper limbs (HP:0008997) help
................... HP:0031108 Triceps weakness
........expandProgressive proximal muscle weakness (HP:0009073) help

 Sister Nodes: 
..expandAbdominal wall muscle weakness (HP:0009023) help
..expandAnkle weakness (HP:0031374) help
..expandAxial muscle weakness (HP:0003327) help
..expandBulbar palsy (HP:0001283) help
..expandCold paresis (HP:0031372) help
..expandDiaphragmatic weakness (HP:0009113) help
..expandDistal muscle weakness (HP:0002460) help
..expandFacial palsy (HP:0010628) help
..expandFatigable weakness (HP:0003473) help
..expandGeneralized muscle weakness (HP:0003324) help
..expandIntercostal muscle weakness (HP:0004878) help
..expandLimb muscle weakness (HP:0003690) help
..expandLimb-girdle muscle weakness (HP:0003325) help
..expandMuscle flaccidity (HP:0010547) help
..expandNeck muscle weakness (HP:0000467) help
..expandPoor head control (HP:0002421) help
..expandProgressive muscle weakness (HP:0003323) help
..expandScapuloperoneal weakness (HP:0003704) help
..expandWeakness of muscles of respiration (HP:0004347) help
..expandWeakness of orbicularis oculi muscle (HP:0012507) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0003701HP:0003701Proximal muscle weakness0ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0003701Proximal muscle weakness0ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0003701Proximal muscle weakness0AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0003701Proximal muscle weakness0AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0003701Proximal muscle weakness0ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0003701Proximal muscle weakness0BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0003701Proximal muscle weakness0BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0003701Proximal muscle weakness0C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0003701Proximal muscle weakness0CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0003701Proximal muscle weakness0CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0003701Proximal muscle weakness0CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0003701Proximal muscle weakness0CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0003701Proximal muscle weakness0CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0003701Proximal muscle weakness0CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0003701Proximal muscle weakness0CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0003701Proximal muscle weakness0COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0003701Proximal muscle weakness0COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0003701Proximal muscle weakness0COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0003701Proximal muscle weakness0COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0003701Proximal muscle weakness0COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0003701Proximal muscle weakness0COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0003701Proximal muscle weakness0COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0003701Proximal muscle weakness0COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0003701Proximal muscle weakness0COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0003701Proximal muscle weakness0COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0003701Proximal muscle weakness0COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0003701Proximal muscle weakness0COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0003701Proximal muscle weakness0CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0003701Proximal muscle weakness0DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0003701Proximal muscle weakness0DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0003701Proximal muscle weakness0DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0003701Proximal muscle weakness0DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0003701Proximal muscle weakness0DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0003701Proximal muscle weakness0FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0003701Proximal muscle weakness0FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0003701Proximal muscle weakness0FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0003701Proximal muscle weakness0FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0003701Proximal muscle weakness0FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0003701Proximal muscle weakness0FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0003701Proximal muscle weakness0FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0003701Proximal muscle weakness0FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0003701Proximal muscle weakness0FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0003701Proximal muscle weakness0FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0003701Proximal muscle weakness0FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0003701Proximal muscle weakness0FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0003701Proximal muscle weakness0GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0003701Proximal muscle weakness0GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0003701Proximal muscle weakness0GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0003701Proximal muscle weakness0GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0003701Proximal muscle weakness0GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0003701Proximal muscle weakness0GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0003701Proximal muscle weakness0HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0003701Proximal muscle weakness0HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0003701Proximal muscle weakness0HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0003701Proximal muscle weakness0JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0003701Proximal muscle weakness0LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0003701Proximal muscle weakness0LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0003701Proximal muscle weakness0LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0003701Proximal muscle weakness0LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0003701Proximal muscle weakness0LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0003701Proximal muscle weakness0MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0003701Proximal muscle weakness0MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0003701Proximal muscle weakness0MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0003701Proximal muscle weakness0MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0003701Proximal muscle weakness0MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0003701Proximal muscle weakness0MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0003701Proximal muscle weakness0MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0003701Proximal muscle weakness0MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0003701Proximal muscle weakness0MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0003701Proximal muscle weakness0MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0003701Proximal muscle weakness0MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0003701Proximal muscle weakness0MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0003701Proximal muscle weakness0MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0003701Proximal muscle weakness0MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0003701Proximal muscle weakness0MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0003701Proximal muscle weakness0NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0003701Proximal muscle weakness0NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0003701Proximal muscle weakness0OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0003701Proximal muscle weakness0ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0003701Proximal muscle weakness0PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0003701Proximal muscle weakness0PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0003701Proximal muscle weakness0PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0003701Proximal muscle weakness0POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0003701Proximal muscle weakness0POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0003701Proximal muscle weakness0POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0003701Proximal muscle weakness0POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0003701Proximal muscle weakness0POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0003701Proximal muscle weakness0PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0003701Proximal muscle weakness0RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0003701Proximal muscle weakness0RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0003701Proximal muscle weakness0RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0003701Proximal muscle weakness0RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0003701Proximal muscle weakness0RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0003701Proximal muscle weakness0SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0003701Proximal muscle weakness0SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0003701Proximal muscle weakness0SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0003701Proximal muscle weakness0SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0003701Proximal muscle weakness0SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0003701Proximal muscle weakness0SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0003701Proximal muscle weakness0SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0003701Proximal muscle weakness0SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0003701Proximal muscle weakness0SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0003701Proximal muscle weakness0SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0003701Proximal muscle weakness0SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0003701Proximal muscle weakness0SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0003701Proximal muscle weakness0SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0003701Proximal muscle weakness0SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0003701Proximal muscle weakness0STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0003701Proximal muscle weakness0STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0003701Proximal muscle weakness0SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0003701Proximal muscle weakness0SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0003701Proximal muscle weakness0SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0003701Proximal muscle weakness0TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0003701Proximal muscle weakness0TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0003701Proximal muscle weakness0TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0003701Proximal muscle weakness0TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0003701Proximal muscle weakness0TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0003701Proximal muscle weakness0TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0003701Proximal muscle weakness0TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0003701Proximal muscle weakness0TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0003701Proximal muscle weakness0TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0003701Proximal muscle weakness0TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0003701Proximal muscle weakness0TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0003701Proximal muscle weakness0TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0003701Proximal muscle weakness0TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0003701Proximal muscle weakness0TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0003701Proximal muscle weakness0TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0003701Proximal muscle weakness0TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0003701Proximal muscle weakness0TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0003701Proximal muscle weakness0VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0003701Proximal muscle weakness0VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0003701Proximal muscle weakness0VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0003701Proximal muscle weakness0VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0003701Proximal muscle weakness0VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0003694Late-onset proximal muscle weakness1ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0003391Gowers sign1ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0009073Progressive proximal muscle weakness1ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0003694Late-onset proximal muscle weakness1ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0003391Gowers sign1ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0009073Progressive proximal muscle weakness1ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0003694Late-onset proximal muscle weakness1AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0003391Gowers sign1AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0009073Progressive proximal muscle weakness1AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0003391Gowers sign1AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0009073Progressive proximal muscle weakness1AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0003694Late-onset proximal muscle weakness1AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0003391Gowers sign1ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0009073Progressive proximal muscle weakness1ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0003694Late-onset proximal muscle weakness1ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0003694Late-onset proximal muscle weakness1BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0003391Gowers sign1BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0009073Progressive proximal muscle weakness1BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0003391Gowers sign1BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0009073Progressive proximal muscle weakness1BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0003694Late-onset proximal muscle weakness1BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0003694Late-onset proximal muscle weakness1C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0003391Gowers sign1C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0009073Progressive proximal muscle weakness1C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0003391Gowers sign1CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0009073Progressive proximal muscle weakness1CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0003694Late-onset proximal muscle weakness1CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0003391Gowers sign1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0009073Progressive proximal muscle weakness1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0003694Late-onset proximal muscle weakness1CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0003391Gowers sign1CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0009073Progressive proximal muscle weakness1CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0003694Late-onset proximal muscle weakness1CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0003391Gowers sign1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0009073Progressive proximal muscle weakness1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0003694Late-onset proximal muscle weakness1CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0003694Late-onset proximal muscle weakness1CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0003391Gowers sign1CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0009073Progressive proximal muscle weakness1CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0003694Late-onset proximal muscle weakness1CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0003391Gowers sign1CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0009073Progressive proximal muscle weakness1CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0003694Late-onset proximal muscle weakness1CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0003391Gowers sign1CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0009073Progressive proximal muscle weakness1CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0003391Gowers sign1COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0009073Progressive proximal muscle weakness1COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0003391Gowers sign1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0003391Gowers sign1COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0003391Gowers sign1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0003391Gowers sign1COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0003391Gowers sign1COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0003391Gowers sign1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0003391Gowers sign1COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0009073Progressive proximal muscle weakness1COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0003694Late-onset proximal muscle weakness1COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0003391Gowers sign1COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0009073Progressive proximal muscle weakness1COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0003694Late-onset proximal muscle weakness1COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0003391Gowers sign1COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0009073Progressive proximal muscle weakness1COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0003694Late-onset proximal muscle weakness1COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0003391Gowers sign1COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0009073Progressive proximal muscle weakness1COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0003391Gowers sign1COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0009073Progressive proximal muscle weakness1COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0003694Late-onset proximal muscle weakness1COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0003391Gowers sign1CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0009073Progressive proximal muscle weakness1CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0003694Late-onset proximal muscle weakness1CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0003391Gowers sign1DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0009073Progressive proximal muscle weakness1DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0003694Late-onset proximal muscle weakness1DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0003694Late-onset proximal muscle weakness1DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0003391Gowers sign1DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0009073Progressive proximal muscle weakness1DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0003694Late-onset proximal muscle weakness1DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0003391Gowers sign1DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0009073Progressive proximal muscle weakness1DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0003391Gowers sign1DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0009073Progressive proximal muscle weakness1DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0003694Late-onset proximal muscle weakness1DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0003694Late-onset proximal muscle weakness1DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0003391Gowers sign1DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0009073Progressive proximal muscle weakness1DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0003694Late-onset proximal muscle weakness1FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0003391Gowers sign1FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0009073Progressive proximal muscle weakness1FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0003694Late-onset proximal muscle weakness1FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0003391Gowers sign1FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0009073Progressive proximal muscle weakness1FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0003694Late-onset proximal muscle weakness1FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0003391Gowers sign1FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0009073Progressive proximal muscle weakness1FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0003694Late-onset proximal muscle weakness1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0003391Gowers sign1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0009073Progressive proximal muscle weakness1FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0003391Gowers sign1FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0009073Progressive proximal muscle weakness1FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0003694Late-onset proximal muscle weakness1FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0003694Late-onset proximal muscle weakness1FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0003391Gowers sign1FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0009073Progressive proximal muscle weakness1FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0003694Late-onset proximal muscle weakness1FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0003391Gowers sign1FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0009073Progressive proximal muscle weakness1FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0003391Gowers sign1FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0009073Progressive proximal muscle weakness1FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0003694Late-onset proximal muscle weakness1FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0003694Late-onset proximal muscle weakness1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0003391Gowers sign1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0009073Progressive proximal muscle weakness1FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0003391Gowers sign1FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0009073Progressive proximal muscle weakness1FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0003694Late-onset proximal muscle weakness1FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0003391Gowers sign1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0009073Progressive proximal muscle weakness1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0003694Late-onset proximal muscle weakness1FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0003694Late-onset proximal muscle weakness1FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0003391Gowers sign1FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0009073Progressive proximal muscle weakness1FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0003694Late-onset proximal muscle weakness1GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0003391Gowers sign1GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0009073Progressive proximal muscle weakness1GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0003391Gowers sign1GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0009073Progressive proximal muscle weakness1GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0003694Late-onset proximal muscle weakness1GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0003694Late-onset proximal muscle weakness1GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0003391Gowers sign1GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0009073Progressive proximal muscle weakness1GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0003694Late-onset proximal muscle weakness1GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0003391Gowers sign1GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0009073Progressive proximal muscle weakness1GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0003694Late-onset proximal muscle weakness1GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0003391Gowers sign1GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0009073Progressive proximal muscle weakness1GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0003391Gowers sign1GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0009073Progressive proximal muscle weakness1GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0003694Late-onset proximal muscle weakness1GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0003391Gowers sign1HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0009073Progressive proximal muscle weakness1HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0003694Late-onset proximal muscle weakness1HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0003391Gowers sign1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0009073Progressive proximal muscle weakness1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0003694Late-onset proximal muscle weakness1HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0003391Gowers sign1HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0009073Progressive proximal muscle weakness1HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0003694Late-onset proximal muscle weakness1HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0003694Late-onset proximal muscle weakness1JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0003391Gowers sign1JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0009073Progressive proximal muscle weakness1JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0003694Late-onset proximal muscle weakness1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0003391Gowers sign1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0009073Progressive proximal muscle weakness1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0003694Late-onset proximal muscle weakness1LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0003391Gowers sign1LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0009073Progressive proximal muscle weakness1LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0003391Gowers sign1LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0009073Progressive proximal muscle weakness1LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0003694Late-onset proximal muscle weakness1LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0003694Late-onset proximal muscle weakness1LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0003391Gowers sign1LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0009073Progressive proximal muscle weakness1LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0003694Late-onset proximal muscle weakness1LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0003391Gowers sign1LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0009073Progressive proximal muscle weakness1LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0003391Gowers sign1MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0009073Progressive proximal muscle weakness1MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0003694Late-onset proximal muscle weakness1MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0003391Gowers sign1MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0009073Progressive proximal muscle weakness1MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0003694Late-onset proximal muscle weakness1MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0003694Late-onset proximal muscle weakness1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0003391Gowers sign1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0009073Progressive proximal muscle weakness1MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0003694Late-onset proximal muscle weakness1MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0003391Gowers sign1MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0009073Progressive proximal muscle weakness1MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0003391Gowers sign1MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0009073Progressive proximal muscle weakness1MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0003694Late-onset proximal muscle weakness1MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0003391Gowers sign1MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0009073Progressive proximal muscle weakness1MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0003694Late-onset proximal muscle weakness1MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0003694Late-onset proximal muscle weakness1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0003391Gowers sign1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0009073Progressive proximal muscle weakness1MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0003694Late-onset proximal muscle weakness1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0003391Gowers sign1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0009073Progressive proximal muscle weakness1MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0003694Late-onset proximal muscle weakness1MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0003391Gowers sign1MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0009073Progressive proximal muscle weakness1MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0003391Gowers sign1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0009073Progressive proximal muscle weakness1MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0003391Gowers sign1MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0009073Progressive proximal muscle weakness1MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0003391Gowers sign1MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0009073Progressive proximal muscle weakness1MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0003391Gowers sign1MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0009073Progressive proximal muscle weakness1MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0003391Gowers sign1MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0009073Progressive proximal muscle weakness1MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0003391Gowers sign1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0009073Progressive proximal muscle weakness1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0003391Gowers sign1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0009073Progressive proximal muscle weakness1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0003694Late-onset proximal muscle weakness1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0003694Late-onset proximal muscle weakness1NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0003391Gowers sign1NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0009073Progressive proximal muscle weakness1NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0003694Late-onset proximal muscle weakness1OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0003391Gowers sign1OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0009073Progressive proximal muscle weakness1OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0003391Gowers sign1ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0009073Progressive proximal muscle weakness1ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0003694Late-onset proximal muscle weakness1ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0003694Late-onset proximal muscle weakness1PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0003391Gowers sign1PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0009073Progressive proximal muscle weakness1PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0003391Gowers sign1PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0009073Progressive proximal muscle weakness1PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0003694Late-onset proximal muscle weakness1PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0003391Gowers sign1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0009073Progressive proximal muscle weakness1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0003694Late-onset proximal muscle weakness1PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0003391Gowers sign1POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0009073Progressive proximal muscle weakness1POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0003694Late-onset proximal muscle weakness1POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0003694Late-onset proximal muscle weakness1POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0003391Gowers sign1POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0009073Progressive proximal muscle weakness1POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0003694Late-onset proximal muscle weakness1POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0003391Gowers sign1POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0009073Progressive proximal muscle weakness1POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0003391Gowers sign1POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0009073Progressive proximal muscle weakness1POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0003694Late-onset proximal muscle weakness1POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0003391Gowers sign1POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0009073Progressive proximal muscle weakness1POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0003694Late-onset proximal muscle weakness1POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0003391Gowers sign1PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0009073Progressive proximal muscle weakness1PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0003694Late-onset proximal muscle weakness1PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0003391Gowers sign1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0009073Progressive proximal muscle weakness1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0003694Late-onset proximal muscle weakness1RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0003694Late-onset proximal muscle weakness1RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0003694Late-onset proximal muscle weakness1RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0003391Gowers sign1RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0003391Gowers sign1RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0009073Progressive proximal muscle weakness1RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0009073Progressive proximal muscle weakness1RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0003694Late-onset proximal muscle weakness1RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0003391Gowers sign1RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0009073Progressive proximal muscle weakness1RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0003694Late-onset proximal muscle weakness1RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0003391Gowers sign1RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0009073Progressive proximal muscle weakness1RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0003391Gowers sign1SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0009073Progressive proximal muscle weakness1SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0003694Late-onset proximal muscle weakness1SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0003391Gowers sign1SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0009073Progressive proximal muscle weakness1SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0003694Late-onset proximal muscle weakness1SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0003391Gowers sign1SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0009073Progressive proximal muscle weakness1SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0003694Late-onset proximal muscle weakness1SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0003391Gowers sign1SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0009073Progressive proximal muscle weakness1SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0003694Late-onset proximal muscle weakness1SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0003694Late-onset proximal muscle weakness1SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0003391Gowers sign1SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0009073Progressive proximal muscle weakness1SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0003694Late-onset proximal muscle weakness1SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0003391Gowers sign1SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0009073Progressive proximal muscle weakness1SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0003694Late-onset proximal muscle weakness1SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0003391Gowers sign1SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0009073Progressive proximal muscle weakness1SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0003694Late-onset proximal muscle weakness1SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0003391Gowers sign1SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0009073Progressive proximal muscle weakness1SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0003694Late-onset proximal muscle weakness1SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0003391Gowers sign1SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0009073Progressive proximal muscle weakness1SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0003391Gowers sign1SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0009073Progressive proximal muscle weakness1SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0003694Late-onset proximal muscle weakness1SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0003694Late-onset proximal muscle weakness1SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0003391Gowers sign1SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0009073Progressive proximal muscle weakness1SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0003694Late-onset proximal muscle weakness1SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0003391Gowers sign1SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0009073Progressive proximal muscle weakness1SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0003694Late-onset proximal muscle weakness1SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0003391Gowers sign1SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0009073Progressive proximal muscle weakness1SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0003694Late-onset proximal muscle weakness1SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0003391Gowers sign1SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0009073Progressive proximal muscle weakness1SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0003694Late-onset proximal muscle weakness1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0003391Gowers sign1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0009073Progressive proximal muscle weakness1STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0003694Late-onset proximal muscle weakness1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0003391Gowers sign1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0009073Progressive proximal muscle weakness1STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0003391Gowers sign1SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0009073Progressive proximal muscle weakness1SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0003694Late-onset proximal muscle weakness1SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0003391Gowers sign1SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0009073Progressive proximal muscle weakness1SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0003694Late-onset proximal muscle weakness1SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0003694Late-onset proximal muscle weakness1SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0003391Gowers sign1SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0009073Progressive proximal muscle weakness1SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0003694Late-onset proximal muscle weakness1TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0003391Gowers sign1TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0009073Progressive proximal muscle weakness1TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0003694Late-onset proximal muscle weakness1TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0003391Gowers sign1TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0009073Progressive proximal muscle weakness1TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0003694Late-onset proximal muscle weakness1TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0003391Gowers sign1TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0009073Progressive proximal muscle weakness1TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0003391Gowers sign1TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0009073Progressive proximal muscle weakness1TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0003694Late-onset proximal muscle weakness1TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0003391Gowers sign1TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0009073Progressive proximal muscle weakness1TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0003694Late-onset proximal muscle weakness1TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0003694Late-onset proximal muscle weakness1TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0003391Gowers sign1TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0009073Progressive proximal muscle weakness1TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0003391Gowers sign1TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0009073Progressive proximal muscle weakness1TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0003694Late-onset proximal muscle weakness1TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0003694Late-onset proximal muscle weakness1TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0003391Gowers sign1TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0009073Progressive proximal muscle weakness1TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0003694Late-onset proximal muscle weakness1TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0003391Gowers sign1TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0009073Progressive proximal muscle weakness1TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0003391Gowers sign1TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0009073Progressive proximal muscle weakness1TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0003694Late-onset proximal muscle weakness1TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0003694Late-onset proximal muscle weakness1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0003391Gowers sign1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0009073Progressive proximal muscle weakness1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0003391Gowers sign1TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0009073Progressive proximal muscle weakness1TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0003694Late-onset proximal muscle weakness1TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0003694Late-onset proximal muscle weakness1TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0003391Gowers sign1TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0009073Progressive proximal muscle weakness1TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0003694Late-onset proximal muscle weakness1TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0003391Gowers sign1TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0009073Progressive proximal muscle weakness1TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0003694Late-onset proximal muscle weakness1TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0003391Gowers sign1TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0009073Progressive proximal muscle weakness1TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0003391Gowers sign1TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0009073Progressive proximal muscle weakness1TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0003694Late-onset proximal muscle weakness1TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0003694Late-onset proximal muscle weakness1TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0003391Gowers sign1TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0009073Progressive proximal muscle weakness1TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0003694Late-onset proximal muscle weakness1VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0003391Gowers sign1VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0009073Progressive proximal muscle weakness1VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0003694Late-onset proximal muscle weakness1VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0003391Gowers sign1VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0009073Progressive proximal muscle weakness1VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0003391Gowers sign1VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0009073Progressive proximal muscle weakness1VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0003694Late-onset proximal muscle weakness1VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0003391Gowers sign1VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0003694Late-onset proximal muscle weakness1VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0009073Progressive proximal muscle weakness1VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0003694Late-onset proximal muscle weakness1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0003391Gowers sign1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0009073Progressive proximal muscle weakness1VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0003731Quadriceps muscle weakness2ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0031108Triceps weakness2ACTA1 CL E G H58255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1506129102610
HP:0003701HP:0003731Quadriceps muscle weakness2ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0031108Triceps weakness2ACTA1 CL E G H58161800Nemaline myopathy 3161800C3711389OMIM1506129102610
HP:0003701HP:0003731Quadriceps muscle weakness2AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0031108Triceps weakness2AGRN CL E G H37579098914ORPHA12176329103320
HP:0003701HP:0031108Triceps weakness2AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0003731Quadriceps muscle weakness2AGRN CL E G H375790615120Myasthenic syndrome, congenital, 8615120C3808739OMIM12176329103320
HP:0003701HP:0031108Triceps weakness2ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0003731Quadriceps muscle weakness2ANO5 CL E G H203859611307Limb-girdle muscular dystrophy, type 2L611307C1969785OMIM1116227337608662
HP:0003701HP:0003731Quadriceps muscle weakness2BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0031108Triceps weakness2BIN1 CL E G H274255200Autosomal recessive centronuclear myopathy255200C0410204OMIM16561052601248
HP:0003701HP:0031108Triceps weakness2BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0003731Quadriceps muscle weakness2BVES CL E G H11149616812Muscular dystrophy, limb-girdle, type 2X616812C4225199OMIM11051152604577
HP:0003701HP:0003731Quadriceps muscle weakness2C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0031108Triceps weakness2C9orf72 CL E G H203228275872ORPHA117728337614260
HP:0003701HP:0031108Triceps weakness2CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0003731Quadriceps muscle weakness2CAPN3 CL E G H825267ORPHA115211480114240
HP:0003701HP:0031108Triceps weakness2CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0003731Quadriceps muscle weakness2CAPN3 CL E G H825618129MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4618129CN253839OMIM115211480114240
HP:0003701HP:0031108Triceps weakness2CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0003731Quadriceps muscle weakness2CASQ1 CL E G H844616231Myopathy, vacuolar, with casq1 aggregates616231C4015624OMIM12491512114250
HP:0003701HP:0031108Triceps weakness2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0003731Quadriceps muscle weakness2CAVIN1 CL E G H284119613327Lipodystrophy, congenital generalized, type 4613327C2750069OMIM11289688603198
HP:0003701HP:0003731Quadriceps muscle weakness2CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0031108Triceps weakness2CHAT CL E G H110398914ORPHA19841912118490
HP:0003701HP:0003731Quadriceps muscle weakness2CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0031108Triceps weakness2CHCHD10 CL E G H400916275872ORPHA129715559615903
HP:0003701HP:0003731Quadriceps muscle weakness2CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0031108Triceps weakness2CNBP CL E G H7555602668Myotonic dystrophy type 2602668C2931689OMIM12413164116955
HP:0003701HP:0003731Quadriceps muscle weakness2COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0031108Triceps weakness2COL13A1 CL E G H130598914ORPHA15592190120350
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0031108Triceps weakness2COL6A1 CL E G H1291158810Bethlem myopathy 1158810CN029274OMIM117182211120220
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0031108Triceps weakness2COL6A1 CL E G H1291254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM117182211120220
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0031108Triceps weakness2COL6A2 CL E G H1292158810Bethlem myopathy 1158810CN029274OMIM119282212120240
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0031108Triceps weakness2COL6A2 CL E G H1292255600Myosclerosis, autosomal recessive255600C1850671OMIM119282212120240
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0031108Triceps weakness2COL6A2 CL E G H1292254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM119282212120240
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0031108Triceps weakness2COL6A3 CL E G H1293158810Bethlem myopathy 1158810CN029274OMIM130012213120250
HP:0003701HP:0003731Quadriceps muscle weakness2COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0031108Triceps weakness2COL6A3 CL E G H1293254090Ullrich congenital muscular dystrophy 1254090CN033863OMIM130012213120250
HP:0003701HP:0003731Quadriceps muscle weakness2COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0031108Triceps weakness2COL9A3 CL E G H1299600969Multiple epiphyseal dysplasia 3600969C1832998OMIM112412219120270
HP:0003701HP:0003731Quadriceps muscle weakness2COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0031108Triceps weakness2COLQ CL E G H829298915ORPHA15422226603033
HP:0003701HP:0003731Quadriceps muscle weakness2COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0031108Triceps weakness2COQ8A CL E G H56997139485ORPHA169916812606980
HP:0003701HP:0031108Triceps weakness2COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0003731Quadriceps muscle weakness2COQ8A CL E G H56997612016Coenzyme Q10 deficiency, primary, 4612016C2677589OMIM169916812606980
HP:0003701HP:0031108Triceps weakness2CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0003731Quadriceps muscle weakness2CPT1C CL E G H126129616282Spastic paraplegia 73, autosomal dominant616282C4225387OMIM123918540608846
HP:0003701HP:0031108Triceps weakness2DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0003731Quadriceps muscle weakness2DGUOK CL E G H1716617070Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4617070C4310733OMIM12392858601465
HP:0003701HP:0003731Quadriceps muscle weakness2DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0031108Triceps weakness2DMD CL E G H175698896ORPHA181842928300377
HP:0003701HP:0003731Quadriceps muscle weakness2DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0031108Triceps weakness2DNM2 CL E G H1785160150Myopathy, centronuclear, 1160150C1834558OMIM110882974602378
HP:0003701HP:0031108Triceps weakness2DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0003731Quadriceps muscle weakness2DPAGT1 CL E G H1798614750Congenital myasthenic syndrome 13614750C3553645OMIM13122995191350
HP:0003701HP:0003731Quadriceps muscle weakness2DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0031108Triceps weakness2DYSF CL E G H8291253601Limb-girdle muscular dystrophy, type 2B253601C1850889OMIM133553097603009
HP:0003701HP:0003731Quadriceps muscle weakness2FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0031108Triceps weakness2FHL1 CL E G H2273300696Myopathy with postural muscle atrophy, X-linked300696C2678055OMIM15863702300163
HP:0003701HP:0003731Quadriceps muscle weakness2FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0031108Triceps weakness2FHL1 CL E G H2273300718Myopathy, reducing body, X-linked, childhood-onset300718C2678015OMIM15863702300163
HP:0003701HP:0003731Quadriceps muscle weakness2FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0031108Triceps weakness2FHL1 CL E G H2273300717Myopathy, reducing body, X-linked, early-onset, severe300717C2678027OMIM15863702300163
HP:0003701HP:0003731Quadriceps muscle weakness2FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0031108Triceps weakness2FHL1 CL E G H2273300695Scapuloperoneal myopathy, X-linked dominant300695C2678061OMIM15863702300163
HP:0003701HP:0031108Triceps weakness2FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0003731Quadriceps muscle weakness2FKRP CL E G H7914734515ORPHA195017997606596
HP:0003701HP:0003731Quadriceps muscle weakness2FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0031108Triceps weakness2FKRP CL E G H79147606612Congenital muscular dystrophy-dystroglycanopathy (with or without mental retardation) type B5606612C1847759OMIM195017997606596
HP:0003701HP:0003731Quadriceps muscle weakness2FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0031108Triceps weakness2FKRP CL E G H79147607155Limb-girdle muscular dystrophy-dystroglycanopathy, type C5607155C1846672OMIM195017997606596
HP:0003701HP:0031108Triceps weakness2FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0003731Quadriceps muscle weakness2FKTN CL E G H2218611615Dilated cardiomyopathy 1X611615C1969024OMIM19143622607440
HP:0003701HP:0003731Quadriceps muscle weakness2FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0031108Triceps weakness2FLAD1 CL E G H80308255100Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency255100C4310822OMIM123524671610595
HP:0003701HP:0031108Triceps weakness2FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0003731Quadriceps muscle weakness2FLNC CL E G H2318609524Myofibrillar myopathy, filamin C-related609524C1836050OMIM142083756102565
HP:0003701HP:0031108Triceps weakness2FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0003731Quadriceps muscle weakness2FLNC CL E G H2318614065Myopathy, distal, 4614065C3279722OMIM142083756102565
HP:0003701HP:0003731Quadriceps muscle weakness2FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0031108Triceps weakness2FUS CL E G H2521275872ORPHA14744010137070
HP:0003701HP:0003731Quadriceps muscle weakness2GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0031108Triceps weakness2GAA CL E G H2548232300Glycogen storage disease, type II232300C0017921OMIM124424065606800
HP:0003701HP:0031108Triceps weakness2GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0003731Quadriceps muscle weakness2GAN CL E G H8139643ORPHA17774137605379
HP:0003701HP:0003731Quadriceps muscle weakness2GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0031108Triceps weakness2GAN CL E G H8139256850Giant axonal neuropathy256850C1850386OMIM17774137605379
HP:0003701HP:0003731Quadriceps muscle weakness2GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0031108Triceps weakness2GDAP1 CL E G H5433299944ORPHA153715968606598
HP:0003701HP:0003731Quadriceps muscle weakness2GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0031108Triceps weakness2GDAP1 CL E G H54332607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM153715968606598
HP:0003701HP:0031108Triceps weakness2GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0003731Quadriceps muscle weakness2GMPPB CL E G H29925615352Muscular dystrophy-dystroglycanopathy (limb-girdle), type c, 14615352C3714932OMIM136422932615320
HP:0003701HP:0031108Triceps weakness2HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0003731Quadriceps muscle weakness2HNRNPA1 CL E G H317852430ORPHA1805031164017
HP:0003701HP:0031108Triceps weakness2HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0003731Quadriceps muscle weakness2HNRNPA1 CL E G H3178615424Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3615424C3809469OMIM1805031164017
HP:0003701HP:0031108Triceps weakness2HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0003731Quadriceps muscle weakness2HNRNPA2B1 CL E G H318152430ORPHA12955033600124
HP:0003701HP:0003731Quadriceps muscle weakness2JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0031108Triceps weakness2JPH1 CL E G H56704607831Charcot-Marie-Tooth disease type 2K607831C1842983OMIM15714201605266
HP:0003701HP:0003731Quadriceps muscle weakness2LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0031108Triceps weakness2LAMB2 CL E G H391398915ORPHA19156487150325
HP:0003701HP:0003731Quadriceps muscle weakness2LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0031108Triceps weakness2LAMP2 CL E G H3920300257Danon disease300257C0878677OMIM18076501309060
HP:0003701HP:0031108Triceps weakness2LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0003731Quadriceps muscle weakness2LARGE1 CL E G H9215608840Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B6608840C1837229OMIM17866511603590
HP:0003701HP:0003731Quadriceps muscle weakness2LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0031108Triceps weakness2LMNA CL E G H4000605588Charcot-Marie-Tooth disease type 2B1605588C1854154OMIM118146636150330
HP:0003701HP:0003731Quadriceps muscle weakness2LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0031108Triceps weakness2LTBP4 CL E G H842598896ORPHA17736717604710
HP:0003701HP:0031108Triceps weakness2MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0003731Quadriceps muscle weakness2MAP3K20 CL E G H51776617760MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION617760C4540345OMIM136817797609479
HP:0003701HP:0031108Triceps weakness2MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0003731Quadriceps muscle weakness2MFN2 CL E G H9927617087Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2A2B617087C4310725OMIM1122216877608507
HP:0003701HP:0003731Quadriceps muscle weakness2MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0031108Triceps weakness2MFN2 CL E G H9927601152Hereditary motor and sensory neuropathy with optic atrophy601152C0393807OMIM1122216877608507
HP:0003701HP:0003731Quadriceps muscle weakness2MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0031108Triceps weakness2MICU1 CL E G H10367401768ORPHA12651530605084
HP:0003701HP:0031108Triceps weakness2MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0003731Quadriceps muscle weakness2MORC2 CL E G H22880616688Charcot-Marie-Tooth disease, axonal, type 2z616688C4225243OMIM172623573616661
HP:0003701HP:0031108Triceps weakness2MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0003731Quadriceps muscle weakness2MT-ATP6 CL E G H4508644ORPHA17414516060
HP:0003701HP:0003731Quadriceps muscle weakness2MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0031108Triceps weakness2MT-ATP6 CL E G H4508551500Neuropathy ataxia retinitis pigmentosa syndrome551500C1328349OMIM17414516060
HP:0003701HP:0003731Quadriceps muscle weakness2MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0031108Triceps weakness2MTAP CL E G H4507112250Diaphyseal medullary stenosis with malignant fibrous histiocytoma112250C1862177OMIM12517413156540
HP:0003701HP:0003731Quadriceps muscle weakness2MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0031108Triceps weakness2MTMR2 CL E G H8898601382Charcot-Marie-Tooth disease, type 4B1601382C1832399OMIM15407450603557
HP:0003701HP:0003731Quadriceps muscle weakness2MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0031108Triceps weakness2MYH2 CL E G H4620605637Inclusion body myopathy 3605637C1854106OMIM111617572160740
HP:0003701HP:0003731Quadriceps muscle weakness2MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0031108Triceps weakness2MYH7 CL E G H4625255310Congenital myopathy with fiber type disproportion255310C0546264OMIM141067577160760
HP:0003701HP:0003731Quadriceps muscle weakness2MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0031108Triceps weakness2MYO9A CL E G H464998914ORPHA12807608604875
HP:0003701HP:0031108Triceps weakness2MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0003731Quadriceps muscle weakness2MYOT CL E G H9499266ORPHA137212399604103
HP:0003701HP:0031108Triceps weakness2MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0003731Quadriceps muscle weakness2MYOT CL E G H9499609200Myotilinopathy609200C1836607OMIM137212399604103
HP:0003701HP:0003731Quadriceps muscle weakness2MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0031108Triceps weakness2MYOT CL E G H9499182920Spheroid body myopathy182920C1866785OMIM137212399604103
HP:0003701HP:0031108Triceps weakness2NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0003731Quadriceps muscle weakness2NARS2 CL E G H79731616239Combined oxidative phosphorylation deficiency 24616239C4015643OMIM130226274612803
HP:0003701HP:0003731Quadriceps muscle weakness2NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0031108Triceps weakness2NEB CL E G H4703256030Nemaline myopathy 2256030C1850569OMIM185307720161650
HP:0003701HP:0003731Quadriceps muscle weakness2OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0031108Triceps weakness2OAT CL E G H4942258870Ornithine aminotransferase deficiency258870C0599035OMIM16078091613349
HP:0003701HP:0031108Triceps weakness2ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0003731Quadriceps muscle weakness2ORAI1 CL E G H84876615883Myopathy, tubular aggregate, 2615883C4014557OMIM132625896610277
HP:0003701HP:0003731Quadriceps muscle weakness2PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0031108Triceps weakness2PABPN1 CL E G H8106164300Oculopharyngeal muscular dystrophy164300C0270952OMIM1858565602279
HP:0003701HP:0031108Triceps weakness2PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0003731Quadriceps muscle weakness2PLEKHG5 CL E G H57449611067Distal spinal muscular atrophy, autosomal recessive 4611067C1970211OMIM1108029105611101
HP:0003701HP:0031108Triceps weakness2PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0003731Quadriceps muscle weakness2PNPLA2 CL E G H57104610717Neutral lipid storage disease with myopathy610717C1853136OMIM156630802609059
HP:0003701HP:0031108Triceps weakness2POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0003731Quadriceps muscle weakness2POLG CL E G H542870595ORPHA123249179174763
HP:0003701HP:0003731Quadriceps muscle weakness2POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0031108Triceps weakness2POLG CL E G H5428258450Cerebellar ataxia infantile with progressive external ophthalmoplegia258450C1850303OMIM123249179174763
HP:0003701HP:0003731Quadriceps muscle weakness2POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0031108Triceps weakness2POLG CL E G H5428607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM123249179174763
HP:0003701HP:0031108Triceps weakness2POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0003731Quadriceps muscle weakness2POMT2 CL E G H29954613156Congenital muscular dystrophy-dystroglycanopathy with mental retardation, type B2613156C3150416OMIM193619743607439
HP:0003701HP:0031108Triceps weakness2POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0003731Quadriceps muscle weakness2POMT2 CL E G H29954613158Limb-girdle muscular dystrophy-dystroglycanopathy, type C2613158C3150418OMIM193619743607439
HP:0003701HP:0031108Triceps weakness2PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0003731Quadriceps muscle weakness2PRKACA CL E G H5566615830Pigmented nodular adrenocortical disease, primary, 4615830C4014425OMIM1439380601639
HP:0003701HP:0031108Triceps weakness2RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0003731Quadriceps muscle weakness2RBCK1 CL E G H10616615895Polyglucosan body myopathy 1 with or without immunodeficiency615895C4014605OMIM148215864610924
HP:0003701HP:0003731Quadriceps muscle weakness2RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0003731Quadriceps muscle weakness2RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0031108Triceps weakness2RYR1 CL E G H6261424107ORPHA1616410483180901
HP:0003701HP:0031108Triceps weakness2RYR1 CL E G H626198905ORPHA1616410483180901
HP:0003701HP:0003731Quadriceps muscle weakness2RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0031108Triceps weakness2RYR1 CL E G H6261255310Congenital myopathy with fiber type disproportion255310C0546264OMIM1616410483180901
HP:0003701HP:0003731Quadriceps muscle weakness2RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0031108Triceps weakness2RYR1 CL E G H6261255320Minicore myopathy255320C1850674OMIM1616410483180901
HP:0003701HP:0031108Triceps weakness2SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0003731Quadriceps muscle weakness2SDHA CL E G H63893208ORPHA1250310680600857
HP:0003701HP:0031108Triceps weakness2SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0003731Quadriceps muscle weakness2SDHAF1 CL E G H6440963208ORPHA17733867612848
HP:0003701HP:0031108Triceps weakness2SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0003731Quadriceps muscle weakness2SDHB CL E G H63903208ORPHA1124910681185470
HP:0003701HP:0031108Triceps weakness2SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0003731Quadriceps muscle weakness2SDHD CL E G H63923208ORPHA168610683602690
HP:0003701HP:0003731Quadriceps muscle weakness2SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0031108Triceps weakness2SELENON CL E G H57190255310Congenital myopathy with fiber type disproportion255310C0546264OMIM165115999606210
HP:0003701HP:0003731Quadriceps muscle weakness2SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0031108Triceps weakness2SLC18A3 CL E G H657298914ORPHA130510936600336
HP:0003701HP:0003731Quadriceps muscle weakness2SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0031108Triceps weakness2SLC25A1 CL E G H657698914ORPHA156810979190315
HP:0003701HP:0003731Quadriceps muscle weakness2SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0031108Triceps weakness2SLC52A3 CL E G H113278211530Brown-Vialetto-Van Laere syndrome 1211530CN029849OMIM146416187613350
HP:0003701HP:0003731Quadriceps muscle weakness2SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0031108Triceps weakness2SLC5A7 CL E G H6048298914ORPHA145514025608761
HP:0003701HP:0031108Triceps weakness2SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0003731Quadriceps muscle weakness2SLC5A7 CL E G H60482617143Myasthenic syndrome, congenital, 20, presynaptic617143C4310694OMIM145514025608761
HP:0003701HP:0003731Quadriceps muscle weakness2SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0031108Triceps weakness2SMN1 CL E G H6606253400Kugelberg-Welander disease253400C0152109OMIM121711117600354
HP:0003701HP:0003731Quadriceps muscle weakness2SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0031108Triceps weakness2SMN1 CL E G H6606271150Spinal muscular atrophy type 4271150C1838230OMIM121711117600354
HP:0003701HP:0003731Quadriceps muscle weakness2SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0031108Triceps weakness2SNAP25 CL E G H661698914ORPHA121811132600322
HP:0003701HP:0003731Quadriceps muscle weakness2SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0031108Triceps weakness2SQSTM1 CL E G H8878275872ORPHA167711280601530
HP:0003701HP:0003731Quadriceps muscle weakness2STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0031108Triceps weakness2STIM1 CL E G H6786160565Myopathy with tubular aggregates160565C0410207OMIM163511386605921
HP:0003701HP:0003731Quadriceps muscle weakness2STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0031108Triceps weakness2STIM1 CL E G H6786185070Stormorken syndrome185070C1861451OMIM163511386605921
HP:0003701HP:0031108Triceps weakness2SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0003731Quadriceps muscle weakness2SYNE1 CL E G H23345612998Emery-Dreifuss muscular dystrophy 4, autosomal dominant612998C2751807OMIM1578917089608441
HP:0003701HP:0031108Triceps weakness2SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0003731Quadriceps muscle weakness2SYNE2 CL E G H23224612999Emery-Dreifuss muscular dystrophy 5, autosomal dominant612999C2751805OMIM1331417084608442
HP:0003701HP:0003731Quadriceps muscle weakness2SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0031108Triceps weakness2SYT2 CL E G H12783398914ORPHA123211510600104
HP:0003701HP:0003731Quadriceps muscle weakness2TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0031108Triceps weakness2TARDBP CL E G H23435275872ORPHA130911571605078
HP:0003701HP:0003731Quadriceps muscle weakness2TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0031108Triceps weakness2TBK1 CL E G H29110275872ORPHA138211584604834
HP:0003701HP:0003731Quadriceps muscle weakness2TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0031108Triceps weakness2TFG CL E G H10342604484Neuropathy, hereditary motor and sensory, Okinawa type604484C1858338OMIM137311758602498
HP:0003701HP:0031108Triceps weakness2TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0003731Quadriceps muscle weakness2TK2 CL E G H7084617069Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3617069C4310734OMIM144211831188250
HP:0003701HP:0031108Triceps weakness2TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0003731Quadriceps muscle weakness2TMEM43 CL E G H79188614302Emery-Dreifuss muscular dystrophy 7, autosomal dominant614302C3553060OMIM182528472612048
HP:0003701HP:0003731Quadriceps muscle weakness2TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0031108Triceps weakness2TNXB CL E G H7148230839ORPHA1215911976600985
HP:0003701HP:0031108Triceps weakness2TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0003731Quadriceps muscle weakness2TOP3A CL E G H7156618098PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5618098CN253818OMIM139011992601243
HP:0003701HP:0003731Quadriceps muscle weakness2TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0031108Triceps weakness2TPM2 CL E G H7169255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134112011190990
HP:0003701HP:0003731Quadriceps muscle weakness2TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0031108Triceps weakness2TPM3 CL E G H7170255310Congenital myopathy with fiber type disproportion255310C0546264OMIM134312012191030
HP:0003701HP:0031108Triceps weakness2TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0003731Quadriceps muscle weakness2TPM3 CL E G H7170609284Nemaline myopathy 1609284C1836448OMIM134312012191030
HP:0003701HP:0003731Quadriceps muscle weakness2TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0031108Triceps weakness2TRAPPC11 CL E G H60684369840ORPHA198325751614138
HP:0003701HP:0031108Triceps weakness2TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0003731Quadriceps muscle weakness2TRDN CL E G H10345615441Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness615441C3809536OMIM1116512261603283
HP:0003701HP:0003731Quadriceps muscle weakness2TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0031108Triceps weakness2TTN CL E G H7273603689Hereditary myopathy with early respiratory failure603689C1863599OMIM12750312403188840
HP:0003701HP:0003731Quadriceps muscle weakness2TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0031108Triceps weakness2TTN CL E G H7273608807Limb-girdle muscular dystrophy, type 2J608807C1837342OMIM12750312403188840
HP:0003701HP:0031108Triceps weakness2TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0003731Quadriceps muscle weakness2TWNK CL E G H5665270595ORPHA14501160606075
HP:0003701HP:0031108Triceps weakness2TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0003731Quadriceps muscle weakness2TWNK CL E G H56652609286Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 3609286C1836439OMIM14501160606075
HP:0003701HP:0003731Quadriceps muscle weakness2TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0031108Triceps weakness2TWNK CL E G H56652607459Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis607459C1843851OMIM14501160606075
HP:0003701HP:0003731Quadriceps muscle weakness2VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0031108Triceps weakness2VAMP1 CL E G H684398914ORPHA114112642185880
HP:0003701HP:0003731Quadriceps muscle weakness2VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0031108Triceps weakness2VAPB CL E G H9217182980Adult proximal spinal muscular atrophy, autosomal dominant182980C1866777OMIM135912649605704
HP:0003701HP:0031108Triceps weakness2VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0003731Quadriceps muscle weakness2VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0003731Quadriceps muscle weakness2VCP CL E G H741552430ORPHA160712666601023
HP:0003701HP:0031108Triceps weakness2VCP CL E G H7415275872ORPHA160712666601023
HP:0003701HP:0003731Quadriceps muscle weakness2VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
HP:0003701HP:0031108Triceps weakness2VCP CL E G H7415167320Inclusion body myopathy with early-onset paget disease and frontotemporal dementia167320C1833662OMIM160712666601023
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0003701HP:0003701Proximal muscle weakness0BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0003701Proximal muscle weakness0CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0003701Proximal muscle weakness0FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0003701Proximal muscle weakness0HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0003701Proximal muscle weakness0IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0003701Proximal muscle weakness0LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0003701Proximal muscle weakness0MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0003701Proximal muscle weakness0MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0003701Proximal muscle weakness0MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0003701Proximal muscle weakness0NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0003701Proximal muscle weakness0OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0003701Proximal muscle weakness0POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0003701Proximal muscle weakness0SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0003701Proximal muscle weakness0TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0003701Proximal muscle weakness0TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0003701Proximal muscle weakness0TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0003701Proximal muscle weakness0VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0003701Proximal muscle weakness0VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0003391Gowers sign1BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0009073Progressive proximal muscle weakness1BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0003694Late-onset proximal muscle weakness1BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0003391Gowers sign1CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0009073Progressive proximal muscle weakness1CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0003694Late-onset proximal muscle weakness1CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0003391Gowers sign1FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0009073Progressive proximal muscle weakness1FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0003694Late-onset proximal muscle weakness1FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0003391Gowers sign1HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0009073Progressive proximal muscle weakness1HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0003694Late-onset proximal muscle weakness1HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0003391Gowers sign1IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0009073Progressive proximal muscle weakness1IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0003694Late-onset proximal muscle weakness1IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0003391Gowers sign1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0009073Progressive proximal muscle weakness1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0003694Late-onset proximal muscle weakness1LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0003391Gowers sign1MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0009073Progressive proximal muscle weakness1MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0003694Late-onset proximal muscle weakness1MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0003391Gowers sign1MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0009073Progressive proximal muscle weakness1MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0003694Late-onset proximal muscle weakness1MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0003391Gowers sign1MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0009073Progressive proximal muscle weakness1MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0003391Gowers sign1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0009073Progressive proximal muscle weakness1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0003694Late-onset proximal muscle weakness1NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0003694Late-onset proximal muscle weakness1OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0003391Gowers sign1OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0009073Progressive proximal muscle weakness1OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0003694Late-onset proximal muscle weakness1POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0003391Gowers sign1POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0009073Progressive proximal muscle weakness1POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0003391Gowers sign1SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0009073Progressive proximal muscle weakness1SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0003694Late-onset proximal muscle weakness1SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0003694Late-onset proximal muscle weakness1TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0003391Gowers sign1TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0009073Progressive proximal muscle weakness1TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0003694Late-onset proximal muscle weakness1TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0003391Gowers sign1TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0009073Progressive proximal muscle weakness1TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0003694Late-onset proximal muscle weakness1TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0003391Gowers sign1TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0009073Progressive proximal muscle weakness1TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0003694Late-onset proximal muscle weakness1VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0003391Gowers sign1VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0009073Progressive proximal muscle weakness1VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0008994Proximal muscle weakness in lower limbs1VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0003694Late-onset proximal muscle weakness1VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0003391Gowers sign1VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0008997Proximal muscle weakness in upper limbs1VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0009073Progressive proximal muscle weakness1VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0031108Triceps weakness2BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0003731Quadriceps muscle weakness2BTNL2 CL E G H56244797ORPHA0301142606000
HP:0003701HP:0031108Triceps weakness2CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0003731Quadriceps muscle weakness2CHCHD10 CL E G H400916615911Frontotemporal dementia and/or amyotrophic lateral sclerosis 2615911C4014648OMIM029715559615903
HP:0003701HP:0031108Triceps weakness2FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0003731Quadriceps muscle weakness2FBXO38 CL E G H81545615575Distal hereditary motor neuronopathy 2D615575C3711384OMIM058028844608533
HP:0003701HP:0031108Triceps weakness2HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0003731Quadriceps muscle weakness2HLA-DRB1 CL E G H3123797ORPHA0414948142857
HP:0003701HP:0031108Triceps weakness2IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0003731Quadriceps muscle weakness2IGHMBP2 CL E G H3508616155Charcot-Marie-Tooth disease, axonal, type 2S616155C4015349OMIM011385542600502
HP:0003701HP:0031108Triceps weakness2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0003731Quadriceps muscle weakness2LIPE CL E G H3991615980Familial partial lipodystrophy 6615980C4014869OMIM01446621151750
HP:0003701HP:0031108Triceps weakness2MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0003731Quadriceps muscle weakness2MICU1 CL E G H10367615673Myopathy with extrapyramidal signs615673C3810285OMIM02651530605084
HP:0003701HP:0003731Quadriceps muscle weakness2MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0031108Triceps weakness2MYH14 CL E G H79784397744ORPHA0106223212608568
HP:0003701HP:0003731Quadriceps muscle weakness2MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0031108Triceps weakness2MYH7 CL E G H4625160500Myopathy, distal, 1160500CN074249OMIM041067577160760
HP:0003701HP:0031108Triceps weakness2NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0003731Quadriceps muscle weakness2NEFH CL E G H4744616924Charcot-Marie-Tooth disease, axonal, type 2CC616924C4310790OMIM07147737162230
HP:0003701HP:0003731Quadriceps muscle weakness2OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0031108Triceps weakness2OPA1 CL E G H4976165500Dominant hereditary optic atrophy165500C0338508OMIM012248140605290
HP:0003701HP:0003731Quadriceps muscle weakness2POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0031108Triceps weakness2POLG CL E G H5428254886ORPHA023249179174763
HP:0003701HP:0031108Triceps weakness2SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0003731Quadriceps muscle weakness2SYT2 CL E G H127833616040Myasthenic syndrome, congenital, 7, presynaptic616040C4015038OMIM023211510600104
HP:0003701HP:0003731Quadriceps muscle weakness2TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0031108Triceps weakness2TK2 CL E G H7084254886ORPHA044211831188250
HP:0003701HP:0003731Quadriceps muscle weakness2TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0031108Triceps weakness2TNXB CL E G H7148606408Ehlers-Danlos-like syndrome due to tenascin-X deficiency606408C1848029OMIM0215911976600985
HP:0003701HP:0003731Quadriceps muscle weakness2TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0031108Triceps weakness2TTN CL E G H7273178464ORPHA02750312403188840
HP:0003701HP:0003731Quadriceps muscle weakness2VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0031108Triceps weakness2VAPB CL E G H9217608627Amyotrophic lateral sclerosis type 8608627C1837728OMIM035912649605704
HP:0003701HP:0003731Quadriceps muscle weakness2VCP CL E G H7415435387ORPHA060712666601023
HP:0003701HP:0031108Triceps weakness2VCP CL E G H7415435387ORPHA060712666601023


Genes (183) :ABHD5 ACTA1 AGPAT2 AGRN AK9 ALG14 ALG2 ANO5 ASAH1 ATP6 ATP7B BICD2 BIN1 BSCL2 BTNL2 BVES C9ORF72 C9orf72 CACNA1S CAPN3 CASQ1 CAV1 CAVIN1 CFL2 CHAT CHCHD10 CHKB CHRNA1 CHRNB1 CHRND CHRNE CNBP COL12A1 COL13A1 COL6A1 COL6A2 COL6A3 COL9A3 COLQ COQ8A CPT1C CRPPA CRYAB DAG1 DES DGUOK DMD DNA2 DNAJB6 DNM2 DOK7 DPAGT1 DPM3 DYNC1H1 DYSF EMD FBXO38 FHL1 FKRP FKTN FLAD1 FLNC FOS FUS GAA GABRA3 GAN GATM GDAP1 GFPT1 GMPPB HLA-DRB1 HNRNPA1 HNRNPA2B1 IGHMBP2 INPP5K JPH1 KCNE3 KCNJ18 KY LAMA2 LAMB2 LAMP2 LARGE1 LDB3 LIPE LMNA LRP4 LTBP4 MAP3K20 MFN2 MICU1 MORC2 MSTO1 MT-ATP6 MTAP MTMR14 MTMR2 MUSK MYF6 MYH14 MYH2 MYH7 MYO9A MYOT MYPN NARS2 NEB NEFH NEFL OAT OPA1 ORAI1 PABPN1 PIGN PLEC PLEKHG5 PNPLA2 PNPLA8 POGLUT1 POLG POLG2 POMGNT1 POMGNT2 POMK POMT1 POMT2 PPARG PRKACA PYROXD1 RAPSN RBCK1 REEP1 RRM2B RYR1 SCN4A SDHA SDHAF1 SDHB SDHD SELENON SGCA SGCB SGCD SGCG SLC18A3 SLC25A1 SLC25A4 SLC52A3 SLC5A7 SMN1 SNAP25 SPEG SQSTM1 STIM1 SYNE1 SYNE2 SYT2 TARDBP TBK1 TCAP TFG TK2 TMEM43 TNXB TOP3A TPM2 TPM3 TRAPPC11 TRDN TRIM32 TRNE TRNL1 TRNL2 TRNN TRNS1 TRPV4 TTN TWNK VAMP1 VAPB VCP VMA21

Diseases (210) :255310 161800 98914 615120 611307 644 551500 255200 797 616812 275872 267 618129 616231 613327 615911 602668 158810 254090 255600 600969 98915 139485 612016 616282 617070 98896 160150 614750 253601 615575 300696 300718 300717 300695 34515 606612 607155 611615 255100 609524 614065 232300 643 256850 99944 607831 615352 52430 615424 616155 300257 608840 615980 605588 617760 617087 601152 401768 615673 616688 112250 601382 397744 605637 160500 266 609200 182920 616239 256030 616924 258870 165500 615883 164300 611067 610717 254886 70595 258450 607459 613156 613158 615830 615895 98905 424107 255320 3208 211530 617143 253400 271150 160565 185070 612998 612999 616040 604484 617069 614302 230839 606408 618098 609284 369840 615441 178464 603689 608807 609286 182980 608627 435387 167320 98907 97244 97240 528 353327 616228 399096 206549 159950 905 363454 615290 169189 169186 79102 681 610687 457050 616209 602541 608930 608931 610 352479 399058 608810 613818 601419 310200 352470 615156 603511 254300 612937 158600 178400 98863 611588 612718 610542 363623 617404 496689 618138 609452 435660 98855 98853 264 502423 616325 59135 98911 171881 617336 399103 617882 612782 280633 254361 613723 98908 251950 617232 613157 618135 616094 86812 617258 616326 101011 62 119 601287 353 253700 253300 601954 254875 609560 609285 369847 615356 1878 254110 2596 663 181405 310440 98913 99947 437572 254892 609
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.